Equine Artificial Insemination Market To Reach $992.53 Million By 2030

Equine Artificial Insemination Market Growth & Trends

The global equine artificial insemination market size is expected to reach USD 992.53 million by 2030, expanding at a CAGR of 5.80% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is being driven by the emphasis on enhancing equines' genetic features, developments in breeding technology, an increase in the number of veterinarians, and an increase in the number of hospitals performing artificial insemination procedures. Employing artificial insemination increases the number of stallions available and reduces the risk of physical harm to the mare and stallion by permitting the utilization of semen from horses that aren’t available, such as competing sports horse stallions or stallions from abroad.

The COVID-19 pandemic restricted access to artificial insemination solutions including equipment, sperm, and services. As a result, the growth of the market was slowed and sales dropped as well. Due to the owner’s demand for doorstep delivery of artificial insemination services, the market steadily recovered. The number of stallions visiting Stallion AI services in 2020 increased. Furthermore, breeders had a lot more options because stallions who normally battle were not at shows and were available for breeding. Additionally, a lot of stallion owners opted for freezing seminal fluid in 2020.

By law, the Japan Racing Association (JRA), a public company established by the national government, and local government agencies must conduct all authorized racing in Japan. Moreover, according to Japan Association for International Racing and Stud Book, 785 farms have thoroughbred broodmares stabled as of 2021. The majority of these live in Hokkaido's Hidaka region. 251 thoroughbred stallions were registered as studs in Japan in 2021. There were 61 foreign-bred horses and 190 Japanese-bred horses. These stallions make up roughly 92% of those standing in the primary Hokkaido breeding area.

 Request a free sample copy or view report summary: Equine Artificial Insemination Market Report

Equine Artificial Insemination Market Report Highlights

• By solutions, the services segment dominated the market in 2022 with a share of over 40%. The semen segment, on the other hand, is projected to grow at the fastest CAGR of over 6% during the forecast period

• In terms of distribution channel, the private segment dominated the market in 2022 and is also expected to grow at the fastest rate of over 6% in the coming years

• The sports/racing equines segment dominated the market in 2022 in terms of equine type and is also anticipated to grow at the fastest CAGR of over 6% from 2023 to 2030

• In 2022, North America attributed to the highest share of about 30% by region

• Asia Pacific is anticipated to grow at a rate of about 7% owing to the largest racing horses & events in Japan during the forecast period

Equine Artificial Insemination Market Segmentation

Grand View Research has segmented the global equine artificial insemination market based on solutions, distribution channel, equine type, and region:

Equine Artificial Insemination Solution Outlook (Revenue, USD Million, 2018 - 2030)

• Equipment & Consumables

• Semen

• Normal Semen

• Sexed Semen

• Services

Equine Artificial Insemination Equine Type Outlook (Revenue, USD Million, 2018 - 2030)

• Sports/Racing

• Recreation

• Others

Equine Artificial Insemination Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Private

• Public

Equine Artificial Insemination Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

• U.S.

• Canada

• Europe

• UK

• Germany

• France

• Italy

• Spain

• Asia Pacific

• Japan

• China

• India

• Australia

• South Korea

• Latin America

• Brazil

• Mexico

• Argentina

• Middle East & Africa

• South Africa

• Saudi Arabia

List of Key Players of Equine Artificial Insemination Market

• IMV Technologie

• Stallion AI Services

• Zoetis

• Neogen Corporation

• Zerlotti Genetics Ltd

• ERC s.r.o.

• CVS (UK) Limited.

• HOFFMAN A.I. BREEDERS INC.

• Nasco

• Continental Genetics, LLC

• MINITÜB GMBH

• Sussex Equine Hospital